Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1035639024 | 10356390 | 24 | F | 201403 | 20160815 | 20140801 | 20160822 | EXP | CA-ROCHE-1444303 | ROCHE | 70.67 | YR | M | Y | 87.00000 | KG | 20160822 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1035639024 | 10356390 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 225 MG, BIW (EVERY 2 WEEKS) | U | S0059B,S0065E,S0068D | 103976 | 225 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 1035639024 | 10356390 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 10 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 11 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 12 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 13 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 14 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 15 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 16 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 17 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 18 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 19 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 20 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | |||||||
| 1035639024 | 10356390 | 21 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0059B,S0065E,S0068D | 103976 | SOLUTION FOR INJECTION | ||||||||
| 1035639024 | 10356390 | 22 | SS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 23 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 24 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 25 | C | UNIPHYL | THEOPHYLLINE ANHYDROUS | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 26 | C | ALVESCO | CICLESONIDE | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 27 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 28 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 1035639024 | 10356390 | 29 | C | GUAIFENESIN. | GUAIFENESIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1035639024 | 10356390 | 1 | Asthma |
| 1035639024 | 10356390 | 22 | Hypertension |
| 1035639024 | 10356390 | 23 | Product used for unknown indication |
| 1035639024 | 10356390 | 24 | Product used for unknown indication |
| 1035639024 | 10356390 | 25 | Product used for unknown indication |
| 1035639024 | 10356390 | 26 | Product used for unknown indication |
| 1035639024 | 10356390 | 27 | Product used for unknown indication |
| 1035639024 | 10356390 | 28 | Product used for unknown indication |
| 1035639024 | 10356390 | 29 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1035639024 | 10356390 | HO |
| 1035639024 | 10356390 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1035639024 | 10356390 | Abdominal pain upper | |
| 1035639024 | 10356390 | Asthma | |
| 1035639024 | 10356390 | Blood glucose abnormal | |
| 1035639024 | 10356390 | Blood pressure increased | |
| 1035639024 | 10356390 | Bronchitis | |
| 1035639024 | 10356390 | Cough | |
| 1035639024 | 10356390 | Influenza | |
| 1035639024 | 10356390 | Peripheral swelling | |
| 1035639024 | 10356390 | Pneumonia | |
| 1035639024 | 10356390 | Road traffic accident | |
| 1035639024 | 10356390 | Stress | |
| 1035639024 | 10356390 | Throat irritation | |
| 1035639024 | 10356390 | Weight decreased | |
| 1035639024 | 10356390 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1035639024 | 10356390 | 1 | 20130807 | 0 | ||
| 1035639024 | 10356390 | 2 | 20140508 | 0 | ||
| 1035639024 | 10356390 | 3 | 20140522 | 0 | ||
| 1035639024 | 10356390 | 4 | 20140828 | 0 | ||
| 1035639024 | 10356390 | 5 | 20141030 | 0 | ||
| 1035639024 | 10356390 | 6 | 20141113 | 0 | ||
| 1035639024 | 10356390 | 7 | 20141211 | 0 | ||
| 1035639024 | 10356390 | 8 | 20150108 | 0 | ||
| 1035639024 | 10356390 | 9 | 20150219 | 0 | ||
| 1035639024 | 10356390 | 10 | 20150304 | 0 | ||
| 1035639024 | 10356390 | 11 | 20150416 | 0 | ||
| 1035639024 | 10356390 | 12 | 20151015 | 0 | ||
| 1035639024 | 10356390 | 13 | 20151112 | 0 | ||
| 1035639024 | 10356390 | 14 | 20151126 | 0 | ||
| 1035639024 | 10356390 | 15 | 20160331 | 0 | ||
| 1035639024 | 10356390 | 16 | 20160418 | 0 | ||
| 1035639024 | 10356390 | 17 | 20160519 | 0 | ||
| 1035639024 | 10356390 | 18 | 20160613 | 0 | ||
| 1035639024 | 10356390 | 19 | 20160630 | 0 | ||
| 1035639024 | 10356390 | 20 | 20160802 | 0 | ||
| 1035639024 | 10356390 | 21 | 20160815 | 0 | ||
| 1035639024 | 10356390 | 22 | 201408 | 0 |